What Buyers Should Know About Nicotine Product Notifications and Market Restrictions: Global Compliance Guide

Entering a new international market with nicotine-related products requires more than identifying a supplier, negotiating prices, and arranging shipments. Buyers must understand the regulatory requirements that apply to the specific product, its intended use, and the destination country.

Nicotine product notifications and market restrictions play an important role in determining whether a finished product can be legally manufactured, imported, distributed, or sold in a particular market.

For manufacturers, importers, distributors, and procurement teams, understanding these requirements before placing an order can help reduce regulatory risks, avoid shipment delays, and support better supplier selection.

This guide explains the key considerations buyers should review when evaluating nicotine product notifications and international market restrictions.

1. Understanding Nicotine Product Notifications

A product notification is a regulatory submission made to the relevant authority before a product is placed on a market, where the applicable legislation requires it.

Depending on the country and product category, the notification may include:

• Product name and category.
• Manufacturer and importer details.
• Product ingredients and composition.
• Nicotine concentration and specifications.
• Emissions or analytical information, where applicable.
• Product design and packaging information.
• Safety and quality documentation.
• Relevant declarations and supporting reports.

It is important to understand that a product notification is not necessarily the same as regulatory approval or marketing authorisation. Some markets require notification, while others require formal authorisation before sale.

Buyers should confirm the exact regulatory process rather than assuming that submitting a notification automatically makes a product legal to sell.

2. United States: FDA Premarket Authorisation Requirements

In the United States, the Food and Drug Administration (FDA) regulates covered tobacco products containing nicotine from any source, including synthetic nicotine.

The Consolidated Appropriations Act, 2022, clarified FDA’s authority over products containing non-tobacco nicotine. Manufacturers wishing to market covered products must submit a Premarket Tobacco Product Application (PMTA) and obtain FDA marketing authorisation.

Important considerations for buyers include:

• Verify whether the exact finished product has received FDA marketing authorisation.
• Check the manufacturer’s and importer’s applicable FDA registration and product-listing responsibilities.
• Review the product’s regulatory status before arranging commercial imports.
• Confirm that product descriptions and import documentation are accurate.
• Check applicable age restrictions and marketing requirements.

An FDA registration, product listing, or application submission should not be treated as proof of marketing authorisation.

The FDA has also continued enforcement against unauthorised electronic nicotine delivery systems and nicotine pouch products. Its May 2026 enforcement guidance highlights attention to products marketed without required premarket authorisation.

Official references:

• FDA – Regulation and Enforcement of Non-Tobacco Nicotine Products.
• FDA – Enforcement Priorities for Certain New Tobacco Products.

3. European Union: Product Notification Under the Tobacco Products Directive

The European Union has established specific notification and safety requirements for electronic cigarettes and nicotine-containing refill containers under Article 20 of the Tobacco Products Directive (2014/40/EU).

Manufacturers and importers must submit the required product notification to the competent authorities of the relevant Member States through the applicable electronic reporting system.

Under Article 20, notification is generally required six months before the intended placing on the market. A new notification is also required for each substantial modification of the product.

Important requirements for covered e-cigarette products include:

• Product and manufacturer identification.
• Ingredient and nicotine-content information.
• Relevant toxicological and emissions information.
• Applicable product safety and quality requirements.
• Packaging, labelling, and health warnings.
• Compliance with other relevant EU legislation.

The Directive also establishes a maximum nicotine concentration of 20 mg/ml and limits the capacity of nicotine-containing refill containers to 10 ml.

Buyers should remember that these requirements apply to the relevant finished e-cigarette products, not automatically to every bulk nicotine ingredient shipment.

Nicotine pouches and other oral nicotine products require separate assessment because their regulatory treatment may differ between EU Member States.

Official references:

• European Commission – Electronic Cigarettes.
• EUR-Lex – Tobacco Products Directive 2014/40/EU.

4. United Kingdom: MHRA Notification and Product Requirements

The United Kingdom operates a notification system for nicotine-containing vaping products under the Tobacco and Related Products Regulations 2016 (TRPR), as amended.

The Medicines and Healthcare products Regulatory Agency (MHRA) manages the notification scheme for Great Britain and Northern Ireland.

Manufacturers and importers should review the applicable notification process before placing covered vaping products on the market.

Key considerations include:

• Submission of the required product notification.
• Compliance with nicotine concentration and container-size limits.
• Ingredient and emissions information.
• Product packaging and health warnings.
• Relevant manufacturer and importer responsibilities.
• Notification updates when applicable product changes occur.

The UK also has separate restrictions affecting nicotine products and their sale.

From 29 October 2026, age-of-sale restrictions covering vaping and nicotine products apply across the UK. The restrictions include nicotine pouches, strips, and pearls, and cover nicotine regardless of whether it is synthetic or plant-derived. Promotional giveaways and substantial promotional discounts are also restricted under the new rules.

These requirements concern finished consumer products and their sale; buyers of bulk nicotine ingredients should separately assess the rules applicable to their specific supply-chain activity.

Official references:

• MHRA – E-Cigarettes: Regulations for Consumer Products.
• UK Government – Selling Vaping and Nicotine Products.

5. Australia: Additional Restrictions on Nicotine Products

Australia has a specific regulatory framework for vaping products and nicotine-related products, with different requirements depending on product classification and intended use.

Buyers should distinguish between nicotine products regulated as therapeutic goods and other consumer products. The applicable import, supply, and approval requirements may differ.

In July 2026, the Therapeutic Goods Administration (TGA) announced additional restrictions on nicotine pouches. From 24 July 2026, nicotine pouches can no longer be imported through the Personal Importation Scheme, accessed through the Special Access Scheme or Authorised Prescriber Scheme, or compounded by pharmacists under the specified arrangements.

These changes demonstrate why buyers should not assume that a product permitted in one market can automatically be imported or distributed in Australia.

Before arranging a shipment, businesses should verify:

• Product classification and intended use.
• Applicable TGA requirements.
• Import permissions and restrictions.
• Relevant therapeutic goods authorisation.
• Current requirements for the specific product category.

Official reference:
TGA – New Regulations Strengthen Controls on Nicotine Pouches.

6. India: Important Restrictions on Nicotine-Related Products

India has separate regulatory frameworks for tobacco products, electronic cigarettes, and medicinal nicotine products.

The Prohibition of Electronic Cigarettes Act, 2019 prohibits the production, manufacture, import, export, transport, sale, distribution, storage, and advertisement of electronic cigarettes, subject to the Act’s definitions and provisions.

Medicinal nicotine products, such as approved nicotine-replacement therapies, are treated under the applicable medicines framework and should not be confused with ordinary consumer vaping products.

India has also taken action concerning nicotine pouches. A September 2026 Reuters report described a central government direction to states to enforce restrictions against the sale of nicotine pouches, citing concerns about their unapproved status.

Businesses considering the Indian market should therefore verify the exact product category, intended use, applicable drug or tobacco laws, and current government directions before importing or distributing nicotine-related products.

Official references:

• Government of India – Prohibition of Electronic Cigarettes Act, 2019.
• National Tobacco Control Programme – Government of India.

7. Key Documents Buyers Should Request from Suppliers

Before purchasing nicotine-related materials or finished products, buyers should establish a clear documentation checklist.

Depending on the product and intended application, relevant documents may include:

Product and Quality Documents

• Certificate of Analysis (COA).
• Safety Data Sheet (SDS).
• Technical Data Sheet (TDS).
• Product specifications.
• Purity and impurity profile.
• Batch identification and traceability records.

Manufacturing and Supplier Documents

• Manufacturer identification.
• Manufacturing process information.
• Raw material sourcing information, where relevant.
• Quality management documentation.
• Relevant declarations and compliance statements.

Regulatory Documents

• Applicable product notification details.
• Marketing authorisation, where required.
• Import permissions or licences, where applicable.
• Product classification information.
• Market-specific packaging and labelling information.

Buyers should verify that documents relate to the exact product, manufacturer, formulation, and destination market. A supplier’s general compliance statement should not replace product-specific regulatory verification.

Explore McCoy NIC’s Certificate and Documentation page for further information about product-related documentation.

8. How Buyers Can Evaluate Market Restrictions Before Placing an Order

A structured market assessment can help buyers identify regulatory issues before committing to a purchase.

Consider the following steps:

1. Identify the Product Category

Determine whether the purchase involves bulk nicotine, a pharmaceutical ingredient, an e-liquid, a nicotine pouch, or another finished product.

2. Confirm the Intended Use

The regulatory classification may change depending on whether the material is intended for pharmaceutical, industrial, research, or consumer-product applications.

3. Identify the Destination Authority

Check the relevant regulator’s official requirements for the importing country and product category.

4. Verify Notification or Authorisation Status

Determine whether the finished product requires notification, registration, premarket authorisation, or another form of regulatory permission.

5. Review Supplier Documentation

Request the COA, SDS, specifications, manufacturing details, and applicable compliance documents.

6. Confirm Import and Distribution Conditions

Check customs requirements, import permissions, labelling rules, age restrictions, and any applicable sales restrictions.

7. Monitor Regulatory Changes

Market requirements can change. Buyers should periodically review official regulatory updates and confirm that supplier documentation remains current.

9. Why Regulatory Awareness Matters for Long-Term Procurement

Regulatory requirements can directly affect supplier selection, purchasing schedules, inventory planning, and international distribution.

A product that meets technical specifications may still be unsuitable for a particular destination market if the required authorisation is missing or its sale is restricted.

Buyers who assess market requirements early can:

• Reduce the risk of rejected or delayed shipments.
• Avoid purchasing products that cannot be legally marketed.
• Improve supplier qualification procedures.
• Maintain more accurate procurement documentation.
• Plan product launches and market entry more effectively.
• Build stronger relationships with suppliers who understand compliance requirements.